France & United States — Food and Drug Administration
16 shared events · Importance 3 · Last updated Jun 08, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Tech
France: France>>> is the country where the NutriNet-Santé>>> study was conducted, involving volunteers from across the nation.
United States — Food and Drug Administration: United States — Food and Drug Administration>>> is a regulatory body in the USA that the study's authors urged to reconsider additive safety evaluations in light of the new findings.
May 20, 2026 · 20 articles
Business
France: France is the headquarters of Median Technologies and Olea Medical, but the agreement's impact on France is indirect.
United States — Food and Drug Administration: The FDA cleared eyonis LCS, enabling its U.S. commercialization; this regulatory approval is foundational to the agreement.
Jul 30, 2026 · 8 articles
Regulatory
France: France is the headquarters of NicOx, but is not directly impacted by the NDA submission.
United States — Food and Drug Administration: The FDA is reviewing the U.S. NDA for NCX 470, with approval expected in summer 2027. Its decision is critical for the drug's launch in the U.S.
Aug 10, 2026 · 6 articles
Business
France: France is the home country of Sanofi, a key player in the antibody therapeutics market.
United States — Food and Drug Administration: The US FDA provides supportive regulatory frameworks that facilitate product approvals and market growth in North America.
Jul 28, 2026 · 6 articles
International
France: France, through its Navy, has intercepted a Russia-linked oil tanker, demonstrating its commitment to enforcing sanctions against Russia and preventing the financing of the war in Ukraine.
United States — Food and Drug Administration: The United States — Food and Drug Administration is the regulatory body that Revolution Medicines will seek approval from for its experimental pancreatic cancer drug, daraxonrasib.
May 18, 2026 · 316 articles
Regulatory
France: France is mentioned as a country where Carl Zeiss Meditec has employees, but it is not directly affected by this event.
United States — Food and Drug Administration: The FDA granted 510(k) clearance for ZEISS CLINIC 360, a regulatory action that enables the product's commercial launch in the U.S. This clearance is a routine but essential step for medical device software.
Aug 19, 2026 · 6 articles
Business
France: Home country of Innate Pharma, where it is headquartered and listed on Euronext Paris.
United States — Food and Drug Administration: Granted Fast Track and Breakthrough Therapy designations to lacutamab, facilitating its development and review.
Aug 10, 2026 · 10 articles
Domestic
France: French authorities assisted in the cartel dismantlement, contributing to international drug enforcement.
United States — Food and Drug Administration: NAFDAC sent goodwill messages, showing inter-agency cooperation in drug control.
Jun 26, 2026 · 7 articles
Tech
France: France provided data from an observational study on Mogamulizumab treatment in clinical practice.
United States — Food and Drug Administration: The United States — Food and Drug Administration is mentioned as the authority to report adverse reactions to POTELIGEO, indicating its regulatory role.
Jun 10, 2026 · 10 articles
Business
France: AB Science is headquartered in Paris, France.
United States — Food and Drug Administration: The United States — Food and Drug Administration authorized AB Science's confirmatory Phase 3 trial for masitinib in ALS.
Jun 02, 2026 · 7 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how France and United States — Food and Drug Administration interact across events, view sentiment trends, and discover connected entities.
Open Dashboard